IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02068079A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma